• Ortivus posted April-June net sales down 2% to SEK 19.3 million versus the year-earlier quarter.
• Gross margin fell 14 percentage points to 37%, while net loss narrowed to SEK 3.6 million.
• EBITDA loss improved to SEK 2.8 million.
• January-June net sales rose 8% to SEK 40.8 million; net loss narrowed to SEK 4.9 million.
• Strengthened MobiMed with AI-based clinical documentation via a Tortus AI partnership; plans to shift to semi-annual reporting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ortivus AB published the original content used to generate this news brief on August 25, 2026, and is solely responsible for the information contained therein.